Kriya Therapeutics

Shankar Ramaswamy, M.D., Co-Founder and CEO
Palo Alto, CA
Kriya Therapeutics is a next-generation gene therapy company focused on designing and developing transformative gene therapies for highly prevalent diseases. With core operations in the Bay Area, California and Research Triangle Park, North Carolina, Kriya is establishing a platform for the development of gene therapies targeting serious chronic diseases affecting millions of patients. The company’s initial pipeline includes multiple programs for the treatment of metabolic diseases including Type 1 Diabetes, Type 2 Diabetes, and severe obesity.

By using this website you agree to accept our Privacy Policy and Terms & Conditions